Post by
Smokey1958 on May 05, 2022 8:46am
Patience
It appears all there is left in response to this constant meddling is ....patience. Once can grumble about management but the reality is there in ALL the fundamentals and analyses. As has been mentioned before it's not the buying that is surprising ...it's the selling. Unfortunately this is rampant across all exchanges and a multitude of companies and contexts ....ScreenPro just seems to be
The truth is management "appears" to be better than it ever has during this short time ScreenPro has been a public entity. Management has put their money where their mouth is in buying shares and the financials are and continue to look great at least in the near term. Unfortunately Covid is ramping up again across 4 continents which suggests testing is still around for quite some time yet. Hopefully this provides both the capital and time to see what Add Biomedical has to offer.
Not surprisingly Morningstar's Fair Value sp has dipped to $.16 with the debacle of manipulation continuing. Even so it is still terribly undervalued at $.065. The 1-star valuation of significantly overbought and overvalued is still around $1.00. Barchart had dropped back to a 100% SELL last week but rose to an 80% SELL yesterday and is at a 72% SELL today. The 20-Day and 50-Day Moving Averages are still a BUY.
There is not one RATIONAL reason for the sp to be so low. Positive Q1 2022 financials out this month should put to rest that ScreenPro was a one hit (year) wonder ....and thus the value of PATIENCE ....even when it's wearing incredibly thin. I think we all get that.
GLTE!!!
Comment by
SY3XElon on May 05, 2022 9:28am
Morninstar has not rerated this based on Year End financials yet so they are just running off indicators and not a good example right now of true value. Expect a significant drop in valuation from them when they rerate based on the (0.31) EPS
Comment by
MyAli4s on May 05, 2022 9:40am
This post has been removed in accordance with Community Policy